BRAF mutations appear in the first stages of melanocytic tumors [29], whereas individual studies indicated that BRAF mutations have an unfavorable prognosis in patients with melanoma [30,31], which has not been definitively shown in other studies [32]. This evidence concerns the gene BRAF and melanoma.